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ABSTRACT 
Islet transplantation has the potential of reestablishing naturally-regulated insulin 
production in Type 1 diabetic patients. Nevertheless, this procedure is limited due to the 
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low islet survival after transplantation and the lifelong immunosuppression to avoid 
rejection. Islet embedding within a biocompatible matrix provides mechanical 
protection and a physical barrier against the immune system thus, increasing islet 
survival. Alginate is the preferred biomaterial used for embedding insulin-producing 
cells because of its biocompatibility, low toxicity and ease of gelation. However, 
alginate gelation is poorly controlled, affecting its physicochemical properties as an 
injectable biomaterial. Including different concentrations of the phosphate salt Na2HPO4 
in alginate hydrogels, we can modulate their gelation time, tuning their physicochemical 
properties like stiffness and porosity while maintaining an appropriate injectability. 
Moreover, these hydrogels showed good biocompatibility when embedding a rat 
insulinoma cell line, especially at low Na2HPO4 concentrations, indicating that these 
hydrogels have potential as injectable biomaterials for Type 1 Diabetes Mellitus 
treatment.  
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1. INTRODUCTION 
Type 1 Diabetes Mellitus (T1DM) is a metabolic disorder characterized by an 
autoimmune response that promotes the destruction of beta-cells within the pancreatic 
islets, resulting in a lifelong inadequate insulin secretion [1]. The most used therapy is 
the subcutaneous administration of exogenous insulin. Although maintaining 
physiologic blood glucose levels is the key in T1DM treatment, exogenous insulin 
injections fail to provide constant metabolic control leading to hypoglycaemia and 
diabetic complications [2]. Alternatively, pancreatic islet transplantation has the 
potential of reestablishing naturally-regulated insulin production thus, restoring the 
physiologic metabolic glucose control in T1DM patients. Nevertheless, there are some 
issues that make this treatment strategy difficult such as the low islet survival after 
transplantation and the lifelong immunosupression to avoid rejection [2 3]. One of the 
strategies developed to overcome this bottleneck is the islet embedding within a 
biocompatible matrix [4]. The matrix provides mechanical protection and also acts as a 
physical barrier keeping high molecular weight immune system components out, while 
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allowing the diffusion of oxygen, nutrients and therapeutic factors like insulin. In this 
way, islets survival is increased and the required number of pancreatic islets per patient 
can be optimized [3 5].  
Hydrogels are three-dimensional networks composed of cross-linked polymers that 
possess many interesting properties for biomedical applications such as high water 
content, biocompatibility and mechanical properties mimicking the structural and 
mechanical properties of extracellular matrices [6]. Furthermore, a great advantage of 
hydrogel-based cell therapies is that they allow a minimally invasive cell delivery by 
means of hydrogel injection in the transplant site [7]. All these properties have 
converted hydrogels into a biomaterial extensively used in tissue engineering 
applications [8-12]. One of the most used materials is alginate [10]. This is a natural 
polymer isolated from brown algae that can form hydrogels. Besides, it shows great 
properties like biocompatibility, low toxicity and ease of gelation [13]. Among all its 
biomedical applications, alginate has been commonly used in pancreatic islets 
embedding [14 15].  
The most commonly used method for alginate hydrogel preparation is the ionic cross-
linking, where the aqueous alginate solution is combined with ionic cross-linking agents 
such as divalent cations. The modification of the internal hydrogel structure leads to 
changes both on the swelling behavior and the mechanical properties and, therefore, its 
stiffness, which has been described as an important conditioner for the differentiation of 
stem cells towards mature cells [16-18]. For example, in alginate capsules with stiffness 
lower than 10 KPa, human Embryonic Stem Cells are able to grow and promote 
pancreatic differentiation, while in capsules in the range of 22-73KPa of stiffness cell 
proliferation is restricted and pancreatic progenitors induction is strongly suppressed 
[19]. However, gelation is usually poorly controlled which limits effectiveness as an 
injectable biomaterial for tissue engineering applications [20 21]. The ideal gelation 
process of a therapeutically useful hydrogel should be quite fast, in the order of seconds 
to minutes and, at the same time, the hydrogel should remain in a viscous state long 
enough to facilitate its manipulation and injection [20-22]. On this regard, alginate 
gelation process has been modulated by modifying the alginate and/or the Ca2+ ions 
source, achieving, therefore, different ranges of physicochemical properties [20 23]. The 
modulation of alginate has also been described by adding cholic acid from bile acids 
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improving the physicochemical properties, the stability of the alginate hydrogels and the 
viability of the embedded cells [24 25]. The lack of injectability forces to make the 
hydrogel in a mold outside the body and implanting the final gelled product by invasive 
surgical procedure instead of by simple injection. Thus, the practical use of hydrogel-
based therapies in the clinic is significantly restricted [22]. Alternatively, retarding 
agents can be added slowing down the alginate gelling reaction and achieving a better 
control over the gelation rate and a wider working time [13]. Phosphate salts act as 
retarding agents due to the ability of phosphate groups to interact with the Ca2+ source 
producing calcium phosphate. This prevents Ca2+ ions from reacting with sodium 
alginate to form the alginate hydrogel. Once the phosphate compound is depleted, 
alginate can form the hydrogel [13 21]. These properties of alginate have been shown, 
for example, in dental material impressions and orthodontic models [26], where sodium 
phosphate is added to delay the gelation time of the hydrogel, providing longer working 
times when loading in alginate impressions [21 27] as well as their biocompatibility 
with the rat insulinoma cell line INS1E. Hydrogels that gellify too fast, force clinicians 
to manage this technology very quick under stressful daily work conditions. Seeing that 
fast alginate gelation supposes a restriction when it is used as a in injectable biomaterial, 
we have explored the effect of a phosphate salt Na2HPO4 as a retardant agent in order 
to improve its gelation for cell therapy application in T1DM treatment. To that end, we 
have characterized the physicochemical properties of the different alginate hydrogels 
containing Na2HPO4. The novelty of this research resides in the alginate hydrogel 
gelation delay without affecting their injectability, helping, therefore, to their translation 
from bench to the clinic. On this regard, hydrogels with a delayed gelation time would 
add more flexibility to the application of these scaffolds in hospitals. 
 
 
2. MATERIALS AND METHODS 
2.1. Materials 
Ultrapure sodium alginate with molecular weight of 75-200KDa and 
Guluronate/Mannuronate ratio ≥1.5 was purchased from FMC Biopolymer. Calcium 
sulphate dihydrate (CaSO4·2H2O), FITC apoptosis Detection Kit, Cell Counter Kit-8 
(CCK-8) and the In Vitro Toxicology LDH based Assay were purchased from Sigma-
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Aldrich. Di-Sodium Hydrogen Phosphate dyhydrate (Na2HPO4·2H2O) was purchased 
from Panreac. LIVE/DEAD® Viability/Cytotoxicity Kit was purchased from Life 
Technologies, Rat Insulin ELISA kit from Mercodia and the Pierce® BCA Protein 
Assay from Thermo Scientific. In this study, a rat insulinoma cell line called INS1E 
[28] which has been provided by the University of Geneva Medical Center has been 
used. 
2.2. Characterization of alginate hydrogels containing Na2HPO4 
2.2.1. Alginate hydrogel preparation 
Ultrapure sodium alginate (FMC Biopolymer), was dissolved in 1% D-mannitol 
(Sigma-Aldrich) at a concentration of 1.5%. Then, it was filtered through a 0.22µm pore 
Minisart Syringe Filter (Sartorius). For gelation, 2.7mL of 1.5% alginate were mixed 
with 60µL of 1.22M CaSO4·2H2O (Sigma-Aldrich) diluted in 240µL of distilled water 
through two LuerLock syringe (BS Syringe) connected with a Fluid Dispensing 
Connector (Braun). Alginate and CaSO4·2H2O were mixed 15 times until complete 
homogenization. For retardation gelation time, 60µL of Na2HPO4·2H2O (Panreac) were 
added in the cross-linking reaction from the following solutions 0.1M, 0.3M, 0.5M, 
0.6M and 0.9M. Hydrogels were molded between two glass plates with 2 mm spacers, 
obtaining 6, 10 or 14mm diameter discs with a circular punch (Fig 1A). 
2.2.2. Rheology and injectability 
Rheological properties of all hydrogels were measured on the rheometer AR1000 (TA 
instruments. New Castle, United States) with flat plate geometry and compared to 
alginate hydrogels formed without Na2HPO4. Oscillatory shear measurements were 
conducted at 20°C to obtain the gelation time, the elastic modulus (G’) and the viscous 
modulus (G’’). These were determined via time sweep, by dosing 4 drops of 100µL of 
1.5% alginate solution and 8 smaller drops of 5 µL of CaSO4/Na2HPO4 mixture on the 
rheometer platform. Next, all conditions were set with a gap at 400µm, a delay time of 3 
seconds, a displacement of 1e-3 rad and an angular frequency of 1Hz. Then a pre-shear 
of 20001/s was applied to initiate alginate gelation and immediately G’ and G’’ moduli 
measurements were performed as a function of time and gelation time was considered 
6 
 
as the value of the G’ modulus plateau (Fig. 1B). Three independent experiments, with 
three replicates each one, were conducted. 
Injectability of hydrogels was assessed by passing the hydrogel through a syringe at 
25ºC with gauges from 25 to 30. Three independent experiments, with three replicates 
each one, were conducted. 
2.2.3. Homogeneity 
To evaluate homogeneity of all different alginate hydrogels, five discs of 10mm in 
diameter of each hydrogel were weighted (wet weight). Discs were dried at 70ºC in a 
drying oven (J.P. Selecta. Abrera, Spain) for 1 hour and weighed again (dry weight). 
Dry/wet ratios were calculated in three independent experiments with three replicates 
each one. 
2.2.4. Swelling and water content  
To evaluate swelling behavior and water content, discs of 10mm in diameter were 
punched and weighted (wet weight: Ws). Then, all discs were lyophilized (Telstar 
cryodos Freeze Dryer. Terrassa, Spain) and reweighed (dried weight: Wd). Water 
content (Wc) was calculated as: Wc=Ws-Wd. Afterwards, the dried alginate discs were 
placed in DPBS with Ca2+ and Mg2+ to estimate their swelling capacity. At selected 
time points, discs were removed from DPBS and wiped using filter paper, and then 
weighed and returned to DPBS until the swelling ratio reached the equilibrium. 
Swelling ratio (SR) was determined in every time point using the following formulae: 
SR=(Ws-Wd)/Wd. Three independent experiments, with three replicates each one, were 
conducted. 
2.2.5. Compressive properties 
Uniaxial unconfined and confined compression studies were performed to measure the 
compressive properties, Young’s (Es) and aggregated (Ha) moduli and Poisson 
coefficient of all different alginate hydrogels. Young’s modulus is a measurement of the 
elasticity of a material that has been subjected to opposite forces along an axis and the 
aggregated modulus defines the stiffness of a material. Discs of 6mm in diameter were 
punched from each hydrogel and evaluated following the protocol described by Acosta 
Santamaría [29]. An Instron MicroTester 5548 machine (Instron. Massachusetts, United 
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States) was used with a precision of 0.0001 N and 0.001 mm in force and displacement, 
respectively. A monotonic ramp at 1mm/min cross-head velocity was carried out with a 
50 N load cell. From the unconfined compression test data, Es modulus was obtained 
from the slope of the linear region in the stress–strain curve using the initial cross-
section area. From the confined compression test data, the Ha modulus was obtained 
following the same procedure. Poisson coefficient is a constant of a material describing 
the lateral expansion during axial compression, and is defined as the ratio of lateral and 
axial strains and directly deduced from Es and Ha.  Three independent experiments, 
with six replicates each one, were conducted. 
2.2.6. Pore morphology  
Scanning electron microscopy (SEM) images of all different alginate hydrogels were 
acquired. Samples were frozen in liquid nitrogen and subsequently lyophilized (Telstar 
cryodos Freeze Dryer. Terrassa, Spain) for at least 24 hours. Finally, samples were 
coated with a Gold/Palladium thin film and examined with an SEM Inspect™ F50 (FEI 
Company. Hillsboro, United States). 
2.3. Biocompatibility of alginate hydrogels formed with Na2HPO4 containing 
INS1E 
2.3.1. Cell culture conditions in alginate hydrogels  
Rat insulinoma INS1-E cells were cultured in complete medium (RPMI 1640 
supplemented with 10% Fetal Bovine Serum (Gibco), 1% 
penicillin/streptomycin/glutamine (Invitrogen), 1% sodium pyruvate 100mM (Sigma), 
1M HEPES (Lonza) and 0.1% mercaptoethanol (Sigma). 1.5% alginate was mixed with 
5x106 cells/mL and hydrogels were formed following the procedure mentioned above. 
Once alginate had gelled, 14mm flat discs were punched and cultured in a 24 well-plate 
with complete medium in a humidified incubator at 37ºC and 5% CO2. The entire 
procedure was performed under sterile conditions. 
2.3.2 Flow cytometry viability and apoptosis assays 
Viability and apoptosis of INS1E cells embedded within all different alginate hydrogels 
were evaluated. At selected time points, medium was removed and hydrogels were 
dissolved in 1% trisodium citrate dihydrate. Then, cells were collected and stained using 
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the LIVE/DEAD® Viability/Cytotoxicity Kit (Life Technologies), and the Annexin-V-
FITC apoptosis Detection Kit (Sigma-Aldrich). All samples were analyzed using the 
BD FACS Calibur flow cytometer (BD Company. Franklin Lakes, United States). 
Unstained cells and cells stained with calcein or ethidium were established as controls 
in the cell viability assay. Unstained cells and cells stained with annexin or propidium 
iodide were established as controls in the apoptosis assay. Three independent 
experiments, with three replicates each one, were conducted. 
2.3.3 Metabolic activity and cell membrane activity assay 
These assays were determined using the Cell Counter Kit-8 (CCK-8) (Sigma) and the In 
Vitro Toxicology LDH based Assay (Sigma-Aldrich) respectively. In the CCK-8 assay 
the absorbance was recorded using the Infinite M200 microplate reader (TECAN 
Trading AG. Männedorf, Switzerland) at 450nm with reference wavelength set at 
650nm. In the LDH assay the absorbance was read at 490nm, with 690nm measurement 
as background. Membrane damage values from the samples were relativized to 
hydrogels formed without the retardant agent. Three independent experiments were 
conducted with three replicates each. 
 
2.3.4 Glucose-Stimulated Insulin Secretion (GSIS) assay  
To assess the INS1-E cells glucose response, GSIS assay was performed 7 days after 
cell embedding within all different alginate hydrogels. Discs were washed and 
incubated with Krebs-Ringer bicarbonate (KRB) for 30 minutes. Next, KRB was 
replaced with KRB containing 3.3mM glucose and incubated for 2 hours. Then, 
supernatants were collected and discs were washed and incubated for 2 hours in KRB 
containing 16.6mM glucose. Final supernatants were collected. The insulin content of 
collected supernatants was quantified with the Rat Insulin ELISA (Mercodia). Insulin 
concentration was normalized to total protein content determined with the Pierce® BCA 
Protein Assay (Thermo Scientific). Three independent experiments, with three 
replicates each one, were conducted. 
2.3.5 Statistical analysis 
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Statistical analysis was performed with SPSS software, version 21.00.1. Data were 
expressed as means ± standard deviation and differences were considered significant, 
for comparison of groups using ANOVA, Tukey’s Post Hoc Test when p<0.05. 
3. RESULTS 
3.1 Characterization of alginate hydrogels containing Na2HPO4 
3.1.1 Na2HPO4 effect on hydrogels rheological and injectability properties 
The influence of Na2HPO4 on the alginate hydrogels formation was studied by 
oscillatory shear measurements. Elastic modulus (G’) and viscous modulus (G’’) were 
measured as a time function in order to characterize the gelation process. G’ modulus 
values were higher than G’’ modulus values among alginate hydrogels (Table 1), 
indicating an elastic solid-like behavior.  
 
G’ values of hydrogels with 0.1M and 0.3M Na2HPO4 were significantly higher 
than controls (p<0.05), while in alginate hydrogels with higher Na2HPO4 
concentrations, the final G’ modulus diminished significantly (p<0.05), demonstrating 
lower elastic properties. G” moduli were all statistically different than hydrogel without 
Na2HPO4 (p<0.05), except for the hydrogel containing 0.1M Na2HPO4. G’ modulus 
stabilized when hydrogels solidified, establishing the gelation time when the G’ 
modulus reached the plateau. The obtained gelation times differed considerably among 
the different conditions tested (Table 1). The gelation of alginate hydrogels without 
Na2HPO4 was around 4 minutes (4.2±0.2 minutes), while the presence of higher 
concentrations of Na2HPO4 (0.5M, 0.6M and 0.9M) slowed down the gelation process 
significantly (p<0.01). Finally, when injectability was assessed, all hydrogels passed 
through all needles in less than a minute (data not shown). 
3.1.2 Hydrogel homogeneity 
The homogeneity was determined by comparing the hydratation degree of five punched 
discs equidistantly distributed in each alginate hydrogel. Discs were weighted in the 
swollen state (Ws), dried and reweighted (Wd). Homogeneity was calculated as the 
average of the Wd/Ws ratios (Table 2) of the different discs of each hydrogel containing 
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different concentrations of Na2HPO4. No statistical differences among hydrogels were 
detected, indicating that Na2HPO4 does not affect the homogeneity of hydrogels.  
 
3.1.3 Swelling analysis 
The influence of different concentrations of Na2HPO4 on water content and swelling 
properties of alginate hydrogels was assessed. All the hydrogels contained a high 
percentage of water (around 97%) with no significant differences among them (Table 
2). Next, all lyophilized alginate discs were immersed in DPBS in order to calculate the 
swelling ratio at different time points. Water uptake by the hydrogels increased over the 
time until they reached the equilibrium (Fig. 2). Hydrogels containing 0.5M, 0.6M and 
0.9M Na2HPO4 reached the equilibrium within 100-200 minutes, while the rest of the 
hydrogels needed 2 days, indicating that the Na2HPO4 content affects the water uptake 
rate. The final stable swelling ratio of all hydrogels was similar (Fig. 2).  
3.1.4 Compressive properties 
Compressive properties of hydrogels by Young (Es) and Aggregate (Ha) moduli were 
determined by Uniaxial unconfined and confined compression respectively, allowing 
the calculation of Poisson coefficient. All hydrogels followed a similar tendency with 
higher Ha than Es values which was in accordance with the need of applying a higher 
force to deform the hydrogel, because in the unconfined compression test, the hydrogel 
can generate a lateral deformation when a load is applied; while in the confined 
compression test the lateral hydrogel deformation is constrained because the discs are 
placed in a confined space [30]. No statistical differences among hydrogels without 
Na2HPO4 and 0.1 and 0.3M Na2HPO4 hydrogels were appreciated (Table 3). In contrast, 
the presence of 0.5M, 0.6M and 0.9M Na2HPO4 showed lower Es and Ha values than 
hydrogel without Na2HPO4 (p<0.001). Poisson coefficient values did not change among 
all the hydrogels (Table 3). 
 
3.1.5 Pore morphology  
The effect of Na2HPO4 on the internal structure of all hydrogels was examined by SEM.  
Hydrogels showed a microporous internal structure and the degree of alginate cross-
linking and pore size were similar among hydrogels without Na2HPO4 and with 0.1 and 
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0.3M Na2HPO4 (Fig. 3A-C). However, hydrogels with 0.5M, 0.6M and 0.9M Na2HPO4 
showed lower degree of cross-linking leading to an increase of their pore size (Fig. 3D-
F).  
 
3.2. Biocompatibility of alginate hydrogels containing Na2HPO4 with INS1E 
After physicochemical characterization, the biocompatibility of alginate hydrogels 
containing Na2HPO4 was assessed.  
3.2.1 INS1E cell viability and apoptosis 
We quantified the viability of INS1E cells within the different hydrogels by flow 
cytometry. At day 1 after cell embedding, the percentage of dead cells in all the 
hydrogels was higher than at the rest of the time points (Fig. 4A). Hydrogels with 0.5M, 
0.6M and 0.9M Na2HPO4 at day 1 showed significantly higher dead cell percentages 
than the control hydrogel (p<0.05). 7 days after hydrogel formation cell death 
percentages decreased drastically, keeping below 1% until the end of the assay with no 
statistical differences among hydrogels. Hence, solely the highest concentrations of 
Na2HPO4 (over 0.5M) affected cell viability at day 1 after hydrogel formation. 
We also quantified the percentage of apoptotic cells within the hydrogels. Apoptosis 
correlated with cell viability with a dramatical reduction of apoptotic cell percentages at 
day 7 in all the hydrogels, and no statistical differences were detected among the 
samples at any time point (Fig. 4B). Hence, different Na2HPO4 concentrations neither 
promote nor reduce the early apoptotic percentage of INS1E cells within alginate 
hydrogels. 
3.2.2 INS1E cell metabolic activity and membrane integrity 
Next, the effect of Na2HPO4 on the cell metabolic activity over three weeks was 
quantified. The highest metabolic activity of embedded INS1E cells was achieved a 
week after hydrogel formation and, afterwards, it remained stable in alginate hydrogels 
with low concentrations of Na2HPO4. The different Na2HPO4 concentrations did not 
affect the metabolic activity of the embedded cells at day 1, except at 0.9M 
concentration that showed significantly higher metabolic activity than the control 
(p<0.001) (Fig. 5A). At day 7, only hydrogels with 0.6M and 0.9M Na2HPO4 showed a 
significant reduction on the INS1E cell metabolic activity compared to control 
(p<0.001). At day 21, only hydrogels formed with 0.1 and 0.3M Na2HPO4 remained 
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with similar metabolic activity levels than control. The rest of the hydrogels showed a 
significant metabolic activity reduction which was more notorious when the amount of 
Na2HPO4 was higher (p<0.001). The effect of Na2HPO4 on INS1E cell membrane 
integrity was also assessed. No significant differences over three weeks were detected 
among all the hydrogels, except for hydrogels with 0.9M Na2HPO4, which 
demonstrated significantly higher membrane damage comparing to the control at day 1 
(p<0.05), day 7 and 21 (both, p<0.01) (Fig. 5B). 
3.2.3 INS1E cell glucose response 
We finally evaluated the insulin secretory response to different concentration of glucose 
to test the application of these hydrogels in the treatment of T1DM. At day 7, when 
embedded cells showed the highest viability, INS1E cells produced and released insulin 
(Fig. 6), responding to glucose stimuli in all the studied alginate hydrogels. There were 
no significant differences in glucose-stimulated insulin secretion assay among 
hydrogels, except for the hydrogel with 0.9M Na2HPO4 that showed significantly lower 
insulin response after exposure to 16.6mM glucose (p<0.001). 
4. DISCUSSION 
4.1 Characterization of alginate hydrogels containing Na2HPO4 
We have characterized and compared distinct alginate hydrogels formed with varying 
concentrations of Na2HPO4, which allows modulating the gelation time and tuning the 
physicochemical properties of the resultant hydrogels. We have been able to establish 
the most adequate physicochemical properties of an injectable biomaterial that could be 
used as a scaffold for insulin-secreting cells.  
The rheological results showed a stronger elastic behavior, which is characteristic of a 
predominantly solid-like behavior, an important factor for the attachment of therapeutic 
cells [31]. A higher final elastic modulus was observed in hydrogels with 0.1 and 0.3M 
Na2HPO4 than in the control hydrogel, due to the slower release of Ca2+ in the presence 
of HPO42-, resulting in a more uniform dispersion of calcium throughout the hydrogel 
before the cross-linking occurs [20]. However, when the Na2HPO4 concentration 
increased, the elastic properties of the resultant hydrogels diminished significantly. We 
hypothesize that at high Na2HPO4 concentrations, a part of Ca2+ ions are retained as 
CaHPO4, resulting in a lower degree of cross-linking between Ca2+ and sodium alginate, 
leading to a reduction of the elastic properties. This hypothesis based on the Ca2+ ions 
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availability is also reflected on the gelation time, since hydrogels with higher elastic 
properties (low Na2HPO4 concentrations) showed shorter gelation times, while 
hydrogels with lower elastic properties (high Na2HPO4 concentrations) demonstrated 
longer gelation times. Hence, based on their gelation characteristics, alginate hydrogels 
containing low Na2HPO4 concentrations, in the order of 0.1-0.3M, could be good 
candidates as injectable biomaterials.  
Swelling properties are also very useful for studying hydrogels behavior, since it 
depends on the inner morphological structure of the scaffold, and it is related to the 
elastic and mechanical properties of the hydrogel [32-34]. Our results showed that 
Na2HPO4 affects the water uptake rate of alginate hydrogels. Hydrogels containing high 
Na2HPO4 concentrations showed faster water uptake rate which inversely correlated 
with their elastic properties, as hydrogels with faster water uptake rates demonstrated 
lower elastic modulus. Regarding the compressive properties, the tendency of both Es 
and Ha moduli also correlated with the swelling behavior and the elastic properties. 
Alginate hydrogels containing 0.1 and 0.3M Na2HPO4 demonstrated the highest 
stiffness, with Es and Ha values around 9-11KPa, while hydrogels with higher 
Na2HPO4 concentrations were softer, around 5-7KPa. Importantly, all tested alginate 
hydrogels ranged within the described native soft tissues Es values, validating the 
studied alginate hydrogels as 3D matrixes able to mimic the characteristics of native 
soft tissues (0.1KPa to 40KPa) [35 36]. 
SEM analysis provided visual proof of the changes promoted by Na2HPO4 on the 
internal hydrogel structure. Hydrogels with absence of Na2HPO4 or with 0.1 and 0.3M 
Na2HPO4 showed a similar degree of cross-linking as well as similar small pore size, 
which can explain their similar mechanical properties and slower water uptake rate. On 
the contrary, alginate hydrogels containing higher Na2HPO4 concentrations 
demonstrated lower degree of cross-linking and, consequently, a higher pore size. These 
results confirm the hypothesis that Ca2+ ions remain as CaHPO4 providing a lower 
cross-linking degree. Moreover, hydrogels with a bigger pore size showed softer 
mechanical properties and an increased permeability reflected on the higher water 
uptake rate. Similarly, poly-L-lactic acid hydrogels with big pores have shown an 
enhancement of their permeability and a decrease of their mechanical properties [30].  
4.2. Biocompatibility of alginate hydrogels containing Na2HPO4 with INS1E 
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Cell viability and apoptosis assays showed correlation at day 1, when the percentage of 
dead cells and apoptosis were as high as almost 10% and 60% respectively, as a 
consequence of the embedding process itself that generates a huge stress on cells [37]. 
Cell viability was higher in hydrogels containing low Na2HPO4 concentrations (0.1M 
and 0.3M) due to their physicochemical properties. In fact, although the porosity of 
these hydrogels was lower, it did not compromise the nutrient and oxygen diffusion 
through the hydrogel. Also, these scaffolds provided appropriate mechanical signals to 
promote cell proliferation and functionality [30]. Importantly, at day 7, dead cells 
percentages were significantly reduced, cell metabolic activity was the highest and the 
membrane damage level was the lowest over the whole study. 
Focusing on the effect of mechanical properties and porosity over cell behavior, it has 
been described that INSE cells within stiffer hydrogels are not able to proliferate [37]. It 
can be explained by the high alginate concentration that increases the stiffness of the 
scaffold and reduces the pore size causing higher mechanical cell constrain and nutrient 
diffusion problems [38]. All our hydrogels contain 1.5% of alginate, and, consequently, 
their stiffness is lower and show higher porosity than 4% alginate hydrogels. Thus, the 
mechanical stimuli on the cells and nutrient diffusion capacity are different. This fact 
would explain the differences of INS1E cells behavior between 1.5% and 4% alginate 
hydrogels with higher cell viability and metabolic activity in our scaffolds.  
Finally, cells within alginate hydrogels were able to secrete insulin after low and high 
concentrations of glucose stimulation, similarly to INS1E cells in polyacrylamide gels 
with stiffness around 13.4KPa [39]. Cells within all hydrogels demonstrated similar 
secreted insulin levels, except hydrogels containing 0.9M Na2HPO4, which showed 
lower secreted insulin in accordance to its lower metabolic activity. Insulin diffusion 
through the scaffolds was not affected by the smaller pore size of alginate hydrogels 
with low Na2HPO4 (0.1M and 0.3M) as the hydrogel with higher pore size (0.9M 
Na2HPO4) showed lower amount of secreted insulin. Hence, based on our data, it can be 
concluded that 1.5% alginate hydrogels containing 0.1 and 0.3M Na2HPO4, besides 
having great injectability properties and an adequate gelation time, provide the best 
mechanical properties and porosity for INS1E cell support and recovery after hydrogel 
formation. 
 
5. CONCLUSIONS 
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The present study widely deepens on the modulation of alginate gels properties by the 
inclusion of Na2HPO4 as a retardant agent, demonstrating that its addition in the alginate 
hydrogel forming reaction slows down its gelation time, changes its mechanical 
properties as well as its porosity, which are very important parameters for cell survival, 
proliferation and functionality. Hydrogels containing 0.1 and 0.3M Na2HPO4 showed 
the ideal injectable properties for their application in the clinic, as well as a good 
biocompatibility with the preservation of the functionality of INS1E cells. Hence, these 
scaffolds are excellent candidates to be used as injectable biomaterials. 
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CAPTIONS 
Fig. 1. A) Detailed procedure of alginate hydrogels preparation. 1.- 1.5% Alginate 
solution and CaSO4-Na2HPO4 placed in independent syringes. 2.- Syringes connected 
and content mixed. 3.- The resultant mixture spread between two glasses with 2mm 
spacer. 4.- Disk punched from the hydrogel. B) Elastic modulus (G’) through time and 
gelation time determination from rheological measurements. 
Fig. 2. Swelling ratio profile of alginate hydrogels containing different concentrations 
of Na2HPO4 and control without Na2HPO4. 
Fig. 3. Scanning electron microcopy (SEM) images from the cross-section of alginate 
hydrogels. A) Control hydrogel without Na2HPO4. Alginate hydrogels containing 
different Na2HPO4 concentrations: B) 0,1M, C) 0,3M, D) 0,5M, E) 0,6M and F) 0,9M. 
Fig. 4. Effect of different Na2HPO4 concentrations on the viability of INS1E embedded 
within different alginate hydrogels compared to control without Na2HPO4. (A) 
Live/dead analysis and (B) early apoptosis analysis, assessed by flow cytometry. Values 
represent mean±SD. *: p<0.05 compared to control hydrogel. 
Fig. 5. Effect of Na2HPO4 on the metabolic activity and membrane damage of INS1E 
embedded within different alginate hydrogels compared to control without Na2HPO4. 
(A) Metabolic activity and (B) membrane damage analysis. Values represent mean±SD. 
*: p<0.05 compared to control hydrogel. 
Fig. 6. Effect of Na2HPO4 on the insulin secretion of INS1E embedded within alginate 
matrices compared to control without Na2HPO4 by glucose-stimulated insulin secretion 
assay. Values represent mean±SD. *: p<0.05 compared to control hydrogel. 
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Table 1. Rheological properties (G’ and G’’ moduli) and gelation time of alginate 
hydrogels containing different concentrations of Na2HPO4 and control without 
Na2HPO4. Values represent mean±SD. *: p<0.05, **: p<0.01 compared to control 
hydrogel. 
 
  
[Na2HPO4] 
 
Control 0.1M 0.3M 0.5M 0.6M 0.9M 
Elastic 
modulus 
G’(Pa) 
853.2± 
110.2 
1165.5± 
177.8(*) 
1445.6
±55.3 
(*) 
468.6± 
73.9(*) 
483.8± 
97.2(*) 
27.9± 
6.4(*) 
Viscous 
modulus 
G’’(Pa) 
87.4±9.1 108.1±15.7  
120.9±4.5 
(*) 
31.2±2.8(*) 30.5±4.8(*) 6.8±1.2(*) 
Gelation 
time 
(min) 
4.2±0.2 
7.7± 
0.4(**) 
9.9± 
0.2(**) 
73.3± 
7.6(**) 
148.5± 
13.1(**) 
253.3± 
25.2(**) 
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Table 2. Homogeneity and water content of alginate hydrogels containing different 
concentrations of Na2HPO4 and control without Na2HPO4. Values represent mean±SD. 
 
  
[Na2HPO4]  
 
Control 0.1M 0.3M 0.5M 0.6M 0.9M 
Homogeneity 0.3±0.014 0.3±0.007 0.3±0.014 0.3±0.002 0.3±0.014 0.3± 0.010 
Water 
content (%) 97.2±0.7 97.5±0.7 97.2±0.5 97.1±0.6 97.5±0.1 96.1±0.5 
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Table 3. Compressive properties (Young and Aggregate moduli) and Poisson’s 
coefficient of alginate hydrogels containing different concentrations of Na2HPO4 and 
control without Na2HPO4. Values represent mean±SD.***: p<0.001 compared to 
control hydrogel. 
  
[Na2HPO4] 
 
Control 0.1M 0.3M 0.5M 0.6M 0.9M 
Young 
modulus 
(KPa) 
10.1±1.3 9.8±1.0 11.7±2.0 
7.6± 
0.7(***) 
7.9± 
0.9(***) 
5.4± 
1.2(***) 
Aggregate 
modulus 
(KPa) 
1092.7± 
110.4 
1150.3±   
96.8 
1183.4± 
57.6 
741.4± 
109.8(***) 
724.8±      
86.8(***) 
785.5± 
119.2(***) 
Poisson’s 
coefficient 
0.4984± 
0.0002 
0.4986± 
0.0001 
0.4989± 
0.001 
0.4983± 
0.0002 
0.4981± 
0.0001 
0.4986± 
0.0006 
 
 
